DaVita HealthCare Partners Inc (DVA) Insider Trading
- $1,136,270,786.25
- $304,578,535.24
- Sept. 16, 2024
- Berkshire Hathaway Inc
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 16, 2024 | CEO | 50,000 | $165.05 | Sell | $8,252,500.00 | |
| Sept. 13, 2024 | CEO | 9,881 | $162.85 | Sell | $1,609,120.85 | |
| Aug. 27, 2024 | CFO | 64,029 | $155.06 | Sell | $9,928,336.74 | |
| Aug. 26, 2024 | CEO | 32,176 | $155.93 | Sell | $5,017,203.68 | |
| Aug. 15, 2024 | COO | 9,539 | $150.03 | Sell | $1,431,136.17 | |
| Aug. 13, 2024 | Insider | 7,857 | $146.21 | Sell | $1,148,771.97 | |
| May 10, 2024 | Director | 5,030 | $138.81 | Sell | $698,214.30 | |
| Feb. 26, 2024 | CEO | 67,603 | $126.11 | Sell | $8,525,414.33 | |
| Feb. 21, 2024 | COO | 29,488 | $119.81 | Sell | $3,532,957.28 | |
| Feb. 21, 2024 | Insider | 11,285 | $120.73 | Sell | $1,362,438.05 | |
| Feb. 16, 2024 | Insider | 26,164 | $119.64 | Sell | $3,130,260.96 | |
| Aug. 22, 2023 | Insider | 9,794 | $101.81 | Sell | $997,127.14 | |
| May 12, 2023 | Director | 2,196 | $95.26 | Sell | $209,190.96 | |
| May 10, 2023 | CEO | 16,916 | $99.44 | Sell | $1,682,127.04 | |
| May 10, 2023 | Director | 2,449 | $101.61 | Sell | $248,842.89 | |
| May 10, 2023 | Insider | 15,941 | $99.24 | Sell | $1,581,984.84 | |
| March 9, 2023 | Director | 1,431 | $75.13 | Sell | $107,511.03 | |
| March 1, 2023 | Director | 735 | $81.78 | Sell | $60,108.30 | |
| Nov. 1, 2022 | Director | 5,000 | $71.14 | Buy | $355,700.00 | |
| June 23, 2022 | COO | 20,000 | $77.70 | Buy | $1,554,000.00 | |
| June 3, 2022 | Director | 2,320 | $97.42 | Sell | $226,014.40 | |
| Feb. 14, 2022 | Director | 700 | $113.64 | Sell | $79,548.00 | |
| Nov. 23, 2021 | Director | 446 | $102.86 | Sell | $45,875.56 | |
| Aug. 23, 2021 | Director | 365 | $133.09 | Sell | $48,577.85 | |
| Aug. 5, 2021 | Director | 790 | $132.66 | Sell | $104,801.40 | |
| Aug. 5, 2021 | CFO | 37,760 | $131.36 | Sell | $4,960,153.60 | |
| June 22, 2021 | Director | 5,048 | $124.33 | Sell | $627,617.84 | |
| May 24, 2021 | Director | 379 | $123.12 | Sell | $46,662.48 | |
| May 13, 2021 | Director | 1,920 | $126.01 | Sell | $241,939.20 | |
| May 5, 2021 | CEO | 27,053 | $122.22 | Sell | $3,306,417.66 | |
| May 4, 2021 | Director | 1,872 | $122.52 | Sell | $229,357.44 | |
| May 3, 2021 | Insider | 5,290 | $118.36 | Sell | $626,124.40 | |
| March 22, 2021 | Director | 436 | $109.51 | Sell | $47,746.36 | |
| Nov. 30, 2020 | COO | 25,000 | $109.74 | Sell | $2,743,500.00 | |
| Nov. 20, 2020 | Director | 430 | $107.88 | Sell | $46,388.40 | |
| Nov. 17, 2020 | Director | 1,388 | $111.00 | Sell | $154,068.00 | |
| Sept. 22, 2020 | Director | 3,000 | $84.60 | Buy | $253,800.00 | |
| Sept. 18, 2020 | VP | 3,772 | $88.03 | Sell | $332,049.16 | |
| Sept. 17, 2020 | Major Shareholder | 200,000 | $88.00 | Sell | $17,600,000.00 | |
| Aug. 24, 2020 | Director | 578 | $87.02 | Sell | $50,297.56 | |
| June 8, 2020 | Director | 357 | $87.53 | Sell | $31,248.21 | |
| May 22, 2020 | Director | 599 | $78.90 | Sell | $47,261.10 | |
| May 18, 2020 | Director | 5,763 | $82.22 | Sell | $473,833.86 | |
| May 11, 2020 | Chairman | 5,390 | $81.18 | Sell | $437,560.20 | |
| March 20, 2020 | Director | 625 | $71.25 | Sell | $44,531.25 | |
| March 2, 2020 | Director | 7,694 | $80.74 | Sell | $621,213.56 | |
| Feb. 26, 2020 | Director | 20,000 | $80.93 | Sell | $1,618,600.00 | |
| June 7, 2018 | Director | 1,264 | $68.76 | Sell | $86,912.64 | |
| May 22, 2018 | Director | 1,505 | $68.22 | Sell | $102,671.10 | |
| May 14, 2018 | Director | 338 | $66.25 | Sell | $22,392.50 |
Insiders are both buying and selling DaVita HealthCare Partners Inc stock.
The insider traders at DaVita HealthCare Partners Inc are: Berkshire Hathaway Inc, Robert J Margolis, Michael David Staffieri, Javier Rodriguez, Pamela M Arway, Dennis Kogod, James K Hilger, Charles Berg, John M Nehra, Kent J Thiry, Leanne M Zumwalt, R. Ted Weschler, Kathleen Alyce Waters, Kim M Rivera, Laura Mildenberger, Roger Valine, Jeanine Marie Jiganti, William L Roper, Barbara J Desoer, Paula A Price, Joel Ackerman, Barbara J. Desoer, Christopher James Schnarr, Phyllis R Yale, William Roper, Carol Anthony Davidson, David T Shapiro, James Hilger, James O Hearty, John Nehra, Kent Thiry, Kim M. Rivera, Leanne M. Zumwalt, Pamela M. Arway, Paul J Diaz, and Allen Nissenson
The most active insider trader at DaVita HealthCare Partners Inc is Berkshire Hathaway Inc with 23 trades.
Kent J Thiry has sold the most DaVita HealthCare Partners Inc stock with a total value of $97,381,311.77.
Berkshire Hathaway Inc has bought the most DaVita HealthCare Partners Inc stock with a total value of $788,248,093.01.
The most recent insider trade for DaVita HealthCare Partners Inc was on Sept. 16, 2024.
The single biggest insider buy for DaVita HealthCare Partners Inc was from R. Ted Weschler with a total value of $204,034,211.16 on Nov. 8, 2013.
The single biggest insider sell for DaVita HealthCare Partners Inc was from Kent J Thiry with a total value of $31,617,744.65 on May 13, 2013.